Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Prostate-Specific Membrane Antigen(PSMA) Inhibitors are a class of drugs that target specific antigens on the surface of prostate cancer cells. These inhibitors block the growth and spread of tumor cells by binding to PSMA and are often used in targeted therapy and imaging studies.
This report is a detailed and comprehensive analysis for global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostate-Specific Membrane Antigen(PSMA) Inhibitor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, QYAOBIO, ACROBiosystems Group, Shanghai Apeptide Co, Xi'an Ruixi Biotechnology Co., Ltd., SNDPHARM TSCHNOLOFY, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Prostate-Specific Membrane Antigen(PSMA) Inhibitor market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate-Specific Membrane Antigen(PSMA) Inhibitor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, with price, sales quantity, revenue, and global market share of Prostate-Specific Membrane Antigen(PSMA) Inhibitor from 2020 to 2025.
Chapter 3, the Prostate-Specific Membrane Antigen(PSMA) Inhibitor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate-Specific Membrane Antigen(PSMA) Inhibitor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Prostate-Specific Membrane Antigen(PSMA) Inhibitor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostate-Specific Membrane Antigen(PSMA) Inhibitor.
Chapter 14 and 15, to describe Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Prostate-Specific Membrane Antigen(PSMA) Inhibitors are a class of drugs that target specific antigens on the surface of prostate cancer cells. These inhibitors block the growth and spread of tumor cells by binding to PSMA and are often used in targeted therapy and imaging studies.
This report is a detailed and comprehensive analysis for global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2020-2031
Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prostate-Specific Membrane Antigen(PSMA) Inhibitor
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prostate-Specific Membrane Antigen(PSMA) Inhibitor market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include TargetMol, Merck KGaA, DC Chemicals, Biorbyt, MedChemExpress, QYAOBIO, ACROBiosystems Group, Shanghai Apeptide Co, Xi'an Ruixi Biotechnology Co., Ltd., SNDPHARM TSCHNOLOFY, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Prostate-Specific Membrane Antigen(PSMA) Inhibitor market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Small Molecule Inhibitors
- Peptide Inhibitors
- Other
- Scientific Research
- Pharmaceuticals
- TargetMol
- Merck KGaA
- DC Chemicals
- Biorbyt
- MedChemExpress
- QYAOBIO
- ACROBiosystems Group
- Shanghai Apeptide Co
- Xi'an Ruixi Biotechnology Co., Ltd.
- SNDPHARM TSCHNOLOFY
- Hangzhou MolCore BioPharmatech
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Prostate-Specific Membrane Antigen(PSMA) Inhibitor product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor, with price, sales quantity, revenue, and global market share of Prostate-Specific Membrane Antigen(PSMA) Inhibitor from 2020 to 2025.
Chapter 3, the Prostate-Specific Membrane Antigen(PSMA) Inhibitor competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Prostate-Specific Membrane Antigen(PSMA) Inhibitor breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Prostate-Specific Membrane Antigen(PSMA) Inhibitor market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Prostate-Specific Membrane Antigen(PSMA) Inhibitor.
Chapter 14 and 15, to describe Prostate-Specific Membrane Antigen(PSMA) Inhibitor sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Small Molecule Inhibitors
1.3.3 Peptide Inhibitors
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Scientific Research
1.4.3 Pharmaceuticals
1.5 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size & Forecast
1.5.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (2020-2031)
1.5.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 TargetMol
2.1.1 TargetMol Details
2.1.2 TargetMol Major Business
2.1.3 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.1.4 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 TargetMol Recent Developments/Updates
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.2.4 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck KGaA Recent Developments/Updates
2.3 DC Chemicals
2.3.1 DC Chemicals Details
2.3.2 DC Chemicals Major Business
2.3.3 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.3.4 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 DC Chemicals Recent Developments/Updates
2.4 Biorbyt
2.4.1 Biorbyt Details
2.4.2 Biorbyt Major Business
2.4.3 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.4.4 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Biorbyt Recent Developments/Updates
2.5 MedChemExpress
2.5.1 MedChemExpress Details
2.5.2 MedChemExpress Major Business
2.5.3 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.5.4 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 MedChemExpress Recent Developments/Updates
2.6 QYAOBIO
2.6.1 QYAOBIO Details
2.6.2 QYAOBIO Major Business
2.6.3 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.6.4 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 QYAOBIO Recent Developments/Updates
2.7 ACROBiosystems Group
2.7.1 ACROBiosystems Group Details
2.7.2 ACROBiosystems Group Major Business
2.7.3 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.7.4 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 ACROBiosystems Group Recent Developments/Updates
2.8 Shanghai Apeptide Co
2.8.1 Shanghai Apeptide Co Details
2.8.2 Shanghai Apeptide Co Major Business
2.8.3 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.8.4 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Shanghai Apeptide Co Recent Developments/Updates
2.9 Xi'an Ruixi Biotechnology Co., Ltd.
2.9.1 Xi'an Ruixi Biotechnology Co., Ltd. Details
2.9.2 Xi'an Ruixi Biotechnology Co., Ltd. Major Business
2.9.3 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.9.4 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Xi'an Ruixi Biotechnology Co., Ltd. Recent Developments/Updates
2.10 SNDPHARM TSCHNOLOFY
2.10.1 SNDPHARM TSCHNOLOFY Details
2.10.2 SNDPHARM TSCHNOLOFY Major Business
2.10.3 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.10.4 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 SNDPHARM TSCHNOLOFY Recent Developments/Updates
2.11 Hangzhou MolCore BioPharmatech
2.11.1 Hangzhou MolCore BioPharmatech Details
2.11.2 Hangzhou MolCore BioPharmatech Major Business
2.11.3 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.11.4 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hangzhou MolCore BioPharmatech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) INHIBITOR BY MANUFACTURER
3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Manufacturer (2020-2025)
3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Manufacturer (2020-2025)
3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer Market Share in 2024
3.4.3 Top 6 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer Market Share in 2024
3.5 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Overall Company Footprint Analysis
3.5.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Region Footprint
3.5.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Type Footprint
3.5.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Region
4.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2031)
4.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2031)
4.1.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Region (2020-2031)
4.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.3 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.4 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.5 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.6 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
5.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type (2020-2031)
5.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
6.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application (2020-2031)
6.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
7.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
7.3 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
7.3.1 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
7.3.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
8.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
8.3 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
8.3.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
8.3.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Region
9.3.1 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
10.2 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
10.3 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
10.3.1 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
10.3.2 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
11.3.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Drivers
12.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Restraints
12.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prostate-Specific Membrane Antigen(PSMA) Inhibitor and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
13.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Distributors
14.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Small Molecule Inhibitors
1.3.3 Peptide Inhibitors
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Scientific Research
1.4.3 Pharmaceuticals
1.5 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size & Forecast
1.5.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (2020-2031)
1.5.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 TargetMol
2.1.1 TargetMol Details
2.1.2 TargetMol Major Business
2.1.3 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.1.4 TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 TargetMol Recent Developments/Updates
2.2 Merck KGaA
2.2.1 Merck KGaA Details
2.2.2 Merck KGaA Major Business
2.2.3 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.2.4 Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Merck KGaA Recent Developments/Updates
2.3 DC Chemicals
2.3.1 DC Chemicals Details
2.3.2 DC Chemicals Major Business
2.3.3 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.3.4 DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 DC Chemicals Recent Developments/Updates
2.4 Biorbyt
2.4.1 Biorbyt Details
2.4.2 Biorbyt Major Business
2.4.3 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.4.4 Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Biorbyt Recent Developments/Updates
2.5 MedChemExpress
2.5.1 MedChemExpress Details
2.5.2 MedChemExpress Major Business
2.5.3 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.5.4 MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 MedChemExpress Recent Developments/Updates
2.6 QYAOBIO
2.6.1 QYAOBIO Details
2.6.2 QYAOBIO Major Business
2.6.3 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.6.4 QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 QYAOBIO Recent Developments/Updates
2.7 ACROBiosystems Group
2.7.1 ACROBiosystems Group Details
2.7.2 ACROBiosystems Group Major Business
2.7.3 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.7.4 ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 ACROBiosystems Group Recent Developments/Updates
2.8 Shanghai Apeptide Co
2.8.1 Shanghai Apeptide Co Details
2.8.2 Shanghai Apeptide Co Major Business
2.8.3 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.8.4 Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Shanghai Apeptide Co Recent Developments/Updates
2.9 Xi'an Ruixi Biotechnology Co., Ltd.
2.9.1 Xi'an Ruixi Biotechnology Co., Ltd. Details
2.9.2 Xi'an Ruixi Biotechnology Co., Ltd. Major Business
2.9.3 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.9.4 Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Xi'an Ruixi Biotechnology Co., Ltd. Recent Developments/Updates
2.10 SNDPHARM TSCHNOLOFY
2.10.1 SNDPHARM TSCHNOLOFY Details
2.10.2 SNDPHARM TSCHNOLOFY Major Business
2.10.3 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.10.4 SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 SNDPHARM TSCHNOLOFY Recent Developments/Updates
2.11 Hangzhou MolCore BioPharmatech
2.11.1 Hangzhou MolCore BioPharmatech Details
2.11.2 Hangzhou MolCore BioPharmatech Major Business
2.11.3 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
2.11.4 Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Hangzhou MolCore BioPharmatech Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PROSTATE-SPECIFIC MEMBRANE ANTIGEN(PSMA) INHIBITOR BY MANUFACTURER
3.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Manufacturer (2020-2025)
3.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Manufacturer (2020-2025)
3.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer Market Share in 2024
3.4.3 Top 6 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer Market Share in 2024
3.5 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Overall Company Footprint Analysis
3.5.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Region Footprint
3.5.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Type Footprint
3.5.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Region
4.1.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2031)
4.1.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2031)
4.1.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Region (2020-2031)
4.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.3 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.4 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.5 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
4.6 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
5.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type (2020-2031)
5.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
6.2 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application (2020-2031)
6.3 Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
7.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
7.3 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
7.3.1 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
7.3.2 North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
8.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
8.3 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
8.3.1 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
8.3.2 Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Region
9.3.1 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
10.2 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
10.3 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
10.3.1 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
10.3.2 South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Size by Country
11.3.1 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Drivers
12.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Restraints
12.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Prostate-Specific Membrane Antigen(PSMA) Inhibitor and Key Manufacturers
13.2 Manufacturing Costs Percentage of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
13.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Distributors
14.3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. TargetMol Basic Information, Manufacturing Base and Competitors
Table 4. TargetMol Major Business
Table 5. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 6. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. TargetMol Recent Developments/Updates
Table 8. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 9. Merck KGaA Major Business
Table 10. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 11. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Merck KGaA Recent Developments/Updates
Table 13. DC Chemicals Basic Information, Manufacturing Base and Competitors
Table 14. DC Chemicals Major Business
Table 15. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 16. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. DC Chemicals Recent Developments/Updates
Table 18. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 19. Biorbyt Major Business
Table 20. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 21. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Biorbyt Recent Developments/Updates
Table 23. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 24. MedChemExpress Major Business
Table 25. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 26. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. MedChemExpress Recent Developments/Updates
Table 28. QYAOBIO Basic Information, Manufacturing Base and Competitors
Table 29. QYAOBIO Major Business
Table 30. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 31. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. QYAOBIO Recent Developments/Updates
Table 33. ACROBiosystems Group Basic Information, Manufacturing Base and Competitors
Table 34. ACROBiosystems Group Major Business
Table 35. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 36. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. ACROBiosystems Group Recent Developments/Updates
Table 38. Shanghai Apeptide Co Basic Information, Manufacturing Base and Competitors
Table 39. Shanghai Apeptide Co Major Business
Table 40. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 41. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Shanghai Apeptide Co Recent Developments/Updates
Table 43. Xi'an Ruixi Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Xi'an Ruixi Biotechnology Co., Ltd. Major Business
Table 45. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 46. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Xi'an Ruixi Biotechnology Co., Ltd. Recent Developments/Updates
Table 48. SNDPHARM TSCHNOLOFY Basic Information, Manufacturing Base and Competitors
Table 49. SNDPHARM TSCHNOLOFY Major Business
Table 50. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 51. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. SNDPHARM TSCHNOLOFY Recent Developments/Updates
Table 53. Hangzhou MolCore BioPharmatech Basic Information, Manufacturing Base and Competitors
Table 54. Hangzhou MolCore BioPharmatech Major Business
Table 55. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 56. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hangzhou MolCore BioPharmatech Recent Developments/Updates
Table 58. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Manufacturer (2020-2025) & (kg)
Table 59. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Manufacturer (2020-2025) & (USD Million)
Table 60. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Manufacturer (2020-2025) & (US$/g)
Table 61. Market Position of Manufacturers in Prostate-Specific Membrane Antigen(PSMA) Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 62. Head Office and Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Site of Key Manufacturer
Table 63. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Type Footprint
Table 64. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Application Footprint
Table 65. Prostate-Specific Membrane Antigen(PSMA) Inhibitor New Market Entrants and Barriers to Market Entry
Table 66. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 68. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2025) & (kg)
Table 69. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2026-2031) & (kg)
Table 70. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2025) & (USD Million)
Table 71. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2026-2031) & (USD Million)
Table 72. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Region (2020-2025) & (US$/g)
Table 73. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Region (2026-2031) & (US$/g)
Table 74. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 75. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 76. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type (2020-2025) & (USD Million)
Table 77. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type (2026-2031) & (USD Million)
Table 78. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2020-2025) & (US$/g)
Table 79. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2026-2031) & (US$/g)
Table 80. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 81. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 82. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2020-2025) & (US$/g)
Table 85. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2026-2031) & (US$/g)
Table 86. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 87. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 88. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 89. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 90. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 91. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 92. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 95. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 96. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 97. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 98. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 99. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 100. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 101. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 103. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 104. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 105. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 106. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2025) & (kg)
Table 107. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2026-2031) & (kg)
Table 108. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2025) & (USD Million)
Table 109. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2026-2031) & (USD Million)
Table 110. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 111. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 112. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 113. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 114. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 115. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 116. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 117. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 119. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 120. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 121. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 122. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 123. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 124. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 125. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 126. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Material
Table 127. Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Materials
Table 128. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Distributors
Table 129. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Customers
Table 1. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. TargetMol Basic Information, Manufacturing Base and Competitors
Table 4. TargetMol Major Business
Table 5. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 6. TargetMol Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. TargetMol Recent Developments/Updates
Table 8. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 9. Merck KGaA Major Business
Table 10. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 11. Merck KGaA Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Merck KGaA Recent Developments/Updates
Table 13. DC Chemicals Basic Information, Manufacturing Base and Competitors
Table 14. DC Chemicals Major Business
Table 15. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 16. DC Chemicals Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. DC Chemicals Recent Developments/Updates
Table 18. Biorbyt Basic Information, Manufacturing Base and Competitors
Table 19. Biorbyt Major Business
Table 20. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 21. Biorbyt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Biorbyt Recent Developments/Updates
Table 23. MedChemExpress Basic Information, Manufacturing Base and Competitors
Table 24. MedChemExpress Major Business
Table 25. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 26. MedChemExpress Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. MedChemExpress Recent Developments/Updates
Table 28. QYAOBIO Basic Information, Manufacturing Base and Competitors
Table 29. QYAOBIO Major Business
Table 30. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 31. QYAOBIO Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. QYAOBIO Recent Developments/Updates
Table 33. ACROBiosystems Group Basic Information, Manufacturing Base and Competitors
Table 34. ACROBiosystems Group Major Business
Table 35. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 36. ACROBiosystems Group Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. ACROBiosystems Group Recent Developments/Updates
Table 38. Shanghai Apeptide Co Basic Information, Manufacturing Base and Competitors
Table 39. Shanghai Apeptide Co Major Business
Table 40. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 41. Shanghai Apeptide Co Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Shanghai Apeptide Co Recent Developments/Updates
Table 43. Xi'an Ruixi Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 44. Xi'an Ruixi Biotechnology Co., Ltd. Major Business
Table 45. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 46. Xi'an Ruixi Biotechnology Co., Ltd. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Xi'an Ruixi Biotechnology Co., Ltd. Recent Developments/Updates
Table 48. SNDPHARM TSCHNOLOFY Basic Information, Manufacturing Base and Competitors
Table 49. SNDPHARM TSCHNOLOFY Major Business
Table 50. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 51. SNDPHARM TSCHNOLOFY Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. SNDPHARM TSCHNOLOFY Recent Developments/Updates
Table 53. Hangzhou MolCore BioPharmatech Basic Information, Manufacturing Base and Competitors
Table 54. Hangzhou MolCore BioPharmatech Major Business
Table 55. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Product and Services
Table 56. Hangzhou MolCore BioPharmatech Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (kg), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Hangzhou MolCore BioPharmatech Recent Developments/Updates
Table 58. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Manufacturer (2020-2025) & (kg)
Table 59. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Manufacturer (2020-2025) & (USD Million)
Table 60. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Manufacturer (2020-2025) & (US$/g)
Table 61. Market Position of Manufacturers in Prostate-Specific Membrane Antigen(PSMA) Inhibitor, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 62. Head Office and Prostate-Specific Membrane Antigen(PSMA) Inhibitor Production Site of Key Manufacturer
Table 63. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Type Footprint
Table 64. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market: Company Product Application Footprint
Table 65. Prostate-Specific Membrane Antigen(PSMA) Inhibitor New Market Entrants and Barriers to Market Entry
Table 66. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 68. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2025) & (kg)
Table 69. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2026-2031) & (kg)
Table 70. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2025) & (USD Million)
Table 71. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2026-2031) & (USD Million)
Table 72. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Region (2020-2025) & (US$/g)
Table 73. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Region (2026-2031) & (US$/g)
Table 74. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 75. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 76. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type (2020-2025) & (USD Million)
Table 77. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Type (2026-2031) & (USD Million)
Table 78. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2020-2025) & (US$/g)
Table 79. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2026-2031) & (US$/g)
Table 80. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 81. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 82. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application (2020-2025) & (USD Million)
Table 83. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application (2026-2031) & (USD Million)
Table 84. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2020-2025) & (US$/g)
Table 85. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2026-2031) & (US$/g)
Table 86. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 87. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 88. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 89. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 90. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 91. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 92. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 93. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 94. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 95. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 96. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 97. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 98. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 99. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 100. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 101. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 102. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 103. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 104. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 105. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 106. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2020-2025) & (kg)
Table 107. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Region (2026-2031) & (kg)
Table 108. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2020-2025) & (USD Million)
Table 109. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Region (2026-2031) & (USD Million)
Table 110. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 111. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 112. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 113. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 114. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 115. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 116. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 117. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 118. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2020-2025) & (kg)
Table 119. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Type (2026-2031) & (kg)
Table 120. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2020-2025) & (kg)
Table 121. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Application (2026-2031) & (kg)
Table 122. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2020-2025) & (kg)
Table 123. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity by Country (2026-2031) & (kg)
Table 124. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2020-2025) & (USD Million)
Table 125. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Country (2026-2031) & (USD Million)
Table 126. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Material
Table 127. Key Manufacturers of Prostate-Specific Membrane Antigen(PSMA) Inhibitor Raw Materials
Table 128. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Distributors
Table 129. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Typical Customers
LIST OF FIGURES
Figure 1. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Picture
Figure 2. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Type in 2024
Figure 4. Small Molecule Inhibitors Examples
Figure 5. Peptide Inhibitors Examples
Figure 6. Other Examples
Figure 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application in 2024
Figure 9. Scientific Research Examples
Figure 10. Pharmaceuticals Examples
Figure 11. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (2020-2031) & (kg)
Figure 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (2020-2031) & (US$/g)
Figure 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2020-2031) & (US$/g)
Figure 30. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application (2020-2031)
Figure 32. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2020-2031) & (US$/g)
Figure 33. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 45. France Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Region (2020-2031)
Figure 53. China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 56. India Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 73. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Drivers
Figure 74. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Restraints
Figure 75. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor in 2024
Figure 78. Manufacturing Process Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 79. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Picture
Figure 2. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Type in 2024
Figure 4. Small Molecule Inhibitors Examples
Figure 5. Peptide Inhibitors Examples
Figure 6. Other Examples
Figure 7. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application in 2024
Figure 9. Scientific Research Examples
Figure 10. Pharmaceuticals Examples
Figure 11. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 12. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 13. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity (2020-2031) & (kg)
Figure 14. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Price (2020-2031) & (US$/g)
Figure 15. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Manufacturer in 2024
Figure 16. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Manufacturer in 2024
Figure 17. Producer Shipments of Prostate-Specific Membrane Antigen(PSMA) Inhibitor by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 18. Top 3 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer (Revenue) Market Share in 2024
Figure 19. Top 6 Prostate-Specific Membrane Antigen(PSMA) Inhibitor Manufacturer (Revenue) Market Share in 2024
Figure 20. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Region (2020-2031)
Figure 21. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Region (2020-2031)
Figure 22. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 23. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 24. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 25. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 26. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 27. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 28. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Type (2020-2031)
Figure 29. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Type (2020-2031) & (US$/g)
Figure 30. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 31. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Revenue Market Share by Application (2020-2031)
Figure 32. Global Prostate-Specific Membrane Antigen(PSMA) Inhibitor Average Price by Application (2020-2031) & (US$/g)
Figure 33. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 34. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 35. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 36. North America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 37. United States Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 38. Canada Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 39. Mexico Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 40. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 41. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 42. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 43. Europe Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 44. Germany Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 45. France Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 46. United Kingdom Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 47. Russia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 48. Italy Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 49. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 50. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 51. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Region (2020-2031)
Figure 52. Asia-Pacific Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Region (2020-2031)
Figure 53. China Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 54. Japan Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 55. South Korea Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 56. India Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 57. Southeast Asia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 58. Australia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 59. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 60. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 61. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 62. South America Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 63. Brazil Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 64. Argentina Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 65. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Type (2020-2031)
Figure 66. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Application (2020-2031)
Figure 67. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Sales Quantity Market Share by Country (2020-2031)
Figure 68. Middle East & Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value Market Share by Country (2020-2031)
Figure 69. Turkey Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 70. Egypt Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 71. Saudi Arabia Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 72. South Africa Prostate-Specific Membrane Antigen(PSMA) Inhibitor Consumption Value (2020-2031) & (USD Million)
Figure 73. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Drivers
Figure 74. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Restraints
Figure 75. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor in 2024
Figure 78. Manufacturing Process Analysis of Prostate-Specific Membrane Antigen(PSMA) Inhibitor
Figure 79. Prostate-Specific Membrane Antigen(PSMA) Inhibitor Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
